DIAMOND MEDINO CAPITAL
At DMC we believe that by understanding the real needs on the ground in the medical field, promoting collaboration between medicine and engineering, and making appropriate targeted investments we can make the world a better and happier place.
We discover the unpolished gemstones that are the latent talents of medical
researchers, and polish them into glittering diamonds.
We boast connoisseur teams of Japanese experts who are ready to bring advanced technology to markets worldwide.
Game changer, DMC.
We will create the very first ecosystem in countries around the world from Japan, where the technologies focused on specially controlled medical devices and pharmaceuticals, as a result of successful healthcare startups, are quickly returned to society through timely investment and cross-sector partnership.
Professors and specialist doctors familiar with the medical field on the ground and expert in medicine and engineering serve as connoisseurs identifying client needs, engage in technological development and work with our clients until they succeed.
Our team of engineers, armed with broad perspectives and capable of responding to cutting-edge medical needs, will team up with outstanding/perception university professors and medical specialists for peerless technological development.
Our team of leading Japanese financial specialists with rich investment experience can accurately identify technologies, markets and personnel at the initial seed stage, and work closely with promising researchers. We will support your start-up from inception through to your exit strategy.
Our certified pharmaceutical specialists, who are familiar with the internal affairs of regulatory authorities in Japan and the United States, can provide hands-on support to obtain administrative approvals at every stage.
|Ten years since Nov. 2022
|Total size of fund
|Investing in the life science field (medical devices, drug discovery)
|Advisory board installed
|TANAKA Kikinzoku Kogyo K.K., Sumitomo Mitsui Trust Bank, Limited, Nobuyoshi Ehara et al.
|IDEA Audit Firm